基本信息
浏览量:0
职业迁徙
个人简介
I, Dr. Shatrunajay Shukla, currently works at the Ministry of Health & Family Welfare, Government of India, Indian Pharmacopoeia Commission. I have expertise in cancer biology, cellular signalling involving natural products and toxicity profiling of drugs & chemicals. I have a special interest in toxicological studies (in-vitro/in-vivo) of synthesized/extracted nano-materials/chemicals. Currently, I focused on adverse events arises from drugs and devices and involved in public health and safety.
研究兴趣
论文共 21 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shatrunajay Shukla,Bikash Ranjan Meher, Archana Mishra,Shubhang Arora,Vivekanandan Kalaiselvan, Rajeev Singh Raghuvanshi
Indian journal of public healthno. 3 (2024): 424-427
G Aishwarya,Shatrunajay Shukla,Vivekanandan Kalaiselvan,Ramesh K Goyal,Arun K Agarwal, Ashish Sharma,Shubhang Arora,Rajeev Singh Raghuvanshi,Rajani Mathur
Acta Scientific Pharmaceutical Sciencespp.27-42, (2024)
Bulletin of the World Health Organizationno. 6 (2023): 412-417
Applied Drug Research, Clinical Trials and Regulatory Affairsno. 2 (2021): 104-111
Shatrunajay Shukla,Mujeeb Ur Rehman,Ritu Tiwari,Mayank Shukla,Vivekanandan Kalaiselvan, Elavarasan Kandadamy,Jai Prakash
INDIAN JOURNAL OF TRADITIONAL KNOWLEDGEno. 3 (2021): 629-637
引用0浏览0引用
0
0
New Insights into the Future of Pharmacoepidemiology and Drug Safety (2021)
加载更多
作者统计
#Papers: 21
#Citation: 434
H-Index: 8
G-Index: 20
Sociability: 4
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn